NNVC logo

NanoViricides (NNVC) EBITDA

Annual EBITDA

-$7.49 M
+$354.80 K+4.53%

June 30, 2024

Summary

Performance

1-Year Change

+4.53%

3-Year Change

+6.81%

5-Year Change

+3.15%

15-Year Change

+0.37%

NNVC EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

67.94%
NNVC annual EBITDA is higher than 67.94% of companies in Healthcare sector

High & Low

All-time High

$1.93 M
NNVC annual EBITDA is currently -487.94% below its historical high of $1.93 million

3-Year Low

-$8.03 M

Earnings dates

Last Annual Earnings Report Date

Jun 30, 2024
NNVC previous annual earnings announcement was published on Jun 30, 2024

Next Annual Earnings Report Date

N/A
NNVC next annual earnings announcement has not yet been scheduled

OtherNNVCprofitabilitymetrics:

Annual Revenue

-
NNVC annual revenue value is unknown

Annual Net Income

-$8.29 M
NNVC annual net profit is -$8.29 million

Annual EBIT

-$8.24 M
NNVC annual earnings before interest & taxes is -$8.24 million

Annual EPS

-$0.70
NNVC annual earnings per share is -$0.70

Quarterly EBITDA

-$1.83 M
+$1.10 M+37.52%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

0%

5-Year Change

0%

NNVC Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

64.33%
NNVC quarterly EBITDA is higher than 64.33% of companies in Healthcare sector

High & Low

All-time High

$4.10 M
NNVC quarterly EBITDA is currently -144.70% below its historical high of $4.10 million

3-Year Low

-$3.38 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
NNVC previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 15, 2025
NNVC next earnings announcement is scheduled for May 15, 2025

OtherNNVCprofitabilitymetrics:

Quarterly Revenue

-
NNVC quarterly revenue value is unknown

Quarterly Net Income

-$2.03 M
NNVC quarterly net profit is -$2.03 million

Quarterly EBIT

-$2.03 M
NNVC quarterly earnings before interest & taxes is -$2.03 million

Quarterly EPS

-$0.14
NNVC quarterly earnings per share is -$0.14

TTM EBITDA

-$8.59 M
+$80.80 K+0.93%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

0%

5-Year Change

0%

NNVC TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

63.4%
NNVC TTM EBITDA is higher than 63.4% of companies in Healthcare sector

High & Low

All-time High

$1.68 M
NNVC TTM EBITDA is currently -612.32% below its historical high of $1.68 million

3-Year Low

-$8.70 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
NNVC previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 15, 2025
NNVC next earnings announcement is scheduled for May 15, 2025

OtherNNVCprofitabilitymetrics:

TTM Revenue

-
NNVC TTM revenue value is unknown

TTM Net Income

-$9.36 M
NNVC TTM net profit is -$9.36 million

TTM EBIT

-$9.36 M
NNVC TTM earnings before interest & taxes is -$9.36 million

TTM EPS

-$0.72
NNVC TTM earnings per share is -$0.72

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$7.49 M
NNVC annual EBITDA is -$7.49 million

Annual Net Income

-$8.29 M
NNVC annual net profit is -$8.29 million

Annual Interest Expense

$49.80 K
NNVC annual interest expense is $49.80 thousand

Annual Income Tax

-
NNVC annual income tax value is unknown

Annual D&A

$759.00 K
NNVC annual depreciation & amortization is $759.00 thousand

NNVC EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+4.5%0.0%0.0%
3 y3 years+6.8%0.0%0.0%
5 y5 years+3.1%0.0%0.0%

NNVC EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-1.4%+6.8%-32.1%+45.8%-42.0%+1.3%
5 y5-year-1.4%+40.8%-32.1%+76.7%-42.0%+37.4%
alltimeall time-487.9%+40.8%-144.7%+76.7%-612.3%+37.4%

NanoViricides EBITDA History

DateAnnualQuarterlyTTM
Dec 2024
-
-$1.83 M(-37.5%)
-$8.59 M(-0.9%)
Sep 2024
-
-$2.93 M(+35.4%)
-$8.67 M(+15.9%)
Jun 2024
-$7.49 M(-4.5%)
-$2.17 M(+30.1%)
-$7.49 M(-14.0%)
Mar 2024
-
-$1.66 M(-13.0%)
-$8.70 M(+1.8%)
Dec 2023
-
-$1.91 M(+9.7%)
-$8.55 M(+4.3%)
Sep 2023
-
-$1.74 M(-48.4%)
-$8.20 M(+4.5%)
Jun 2023
-$7.84 M(+6.3%)
-$3.38 M(+123.2%)
-$7.84 M(+29.5%)
Mar 2023
-
-$1.51 M(-2.8%)
-$6.05 M(-1.5%)
Dec 2022
-
-$1.56 M(+12.4%)
-$6.14 M(-2.9%)
Sep 2022
-
-$1.39 M(-13.0%)
-$6.33 M(-14.2%)
Jun 2022
-$7.38 M(-8.1%)
-$1.59 M(-0.8%)
-$7.38 M(-3.9%)
Mar 2022
-
-$1.61 M(-7.7%)
-$7.67 M(-4.1%)
Dec 2021
-
-$1.74 M(-28.5%)
-$8.00 M(-4.5%)
Sep 2021
-
-$2.44 M(+29.0%)
-$8.37 M(+4.3%)
Jun 2021
-$8.03 M(-36.5%)
-$1.89 M(-2.2%)
-$8.03 M(+3.0%)
Mar 2021
-
-$1.93 M(-8.8%)
-$7.79 M(-43.2%)
Dec 2020
-
-$2.12 M(+1.3%)
-$13.73 M(+2.8%)
Sep 2020
-
-$2.09 M(+26.3%)
-$13.36 M(+5.6%)
Jun 2020
-$12.65 M(+63.7%)
-$1.66 M(-79.0%)
-$12.65 M(-2.9%)
Mar 2020
-
-$7.86 M(+349.7%)
-$13.04 M(+82.6%)
Dec 2019
-
-$1.75 M(+26.1%)
-$7.14 M(-4.1%)
Sep 2019
-
-$1.39 M(-32.0%)
-$7.45 M(-6.0%)
Jun 2019
-$7.73 M(+5.3%)
-$2.04 M(+3.7%)
-$7.93 M(+7.6%)
Mar 2019
-
-$1.97 M(-4.4%)
-$7.37 M(+0.4%)
Dec 2018
-
-$2.06 M(+10.3%)
-$7.34 M(-5.1%)
Sep 2018
-
-$1.87 M(+26.2%)
-$7.73 M(+5.4%)
Jun 2018
-$7.34 M(-2.3%)
-$1.48 M(-23.8%)
-$7.34 M(-7.1%)
Mar 2018
-
-$1.94 M(-20.8%)
-$7.90 M(-6.7%)
Dec 2017
-
-$2.45 M(+66.2%)
-$8.47 M(+25.7%)
Sep 2017
-
-$1.47 M(-27.9%)
-$6.74 M(-10.3%)
Jun 2017
-$7.51 M(-1.1%)
-$2.04 M(-18.6%)
-$7.51 M(+18.8%)
Mar 2017
-
-$2.51 M(+251.7%)
-$6.33 M(-20.7%)
Dec 2016
-
-$713.60 K(-68.3%)
-$7.98 M(-14.0%)
Sep 2016
-
-$2.25 M(+163.0%)
-$9.27 M(+22.2%)
Jun 2016
-$7.60 M(-493.6%)
-$854.50 K(-79.5%)
-$7.59 M(+8.9%)
Mar 2016
-
-$4.16 M(+107.1%)
-$6.97 M(+784.3%)
Dec 2015
-
-$2.01 M(+256.0%)
-$788.20 K(+1996.3%)
Sep 2015
-
-$564.60 K(+141.6%)
-$37.60 K(-102.2%)
DateAnnualQuarterlyTTM
Jun 2015
$1.93 M(-119.8%)
-$233.70 K(-111.6%)
$1.68 M(-138.6%)
Mar 2015
-
$2.02 M(-260.4%)
-$4.35 M(+91.6%)
Dec 2014
-
-$1.26 M(-209.5%)
-$2.27 M(+3.5%)
Sep 2014
-
$1.15 M(-118.4%)
-$2.19 M(-77.2%)
Jun 2014
-$9.73 M(+28.6%)
-$6.26 M(-252.7%)
-$9.59 M(+86.6%)
Mar 2014
-
$4.10 M(-446.5%)
-$5.14 M(-57.3%)
Dec 2013
-
-$1.18 M(-81.1%)
-$12.04 M(-0.1%)
Sep 2013
-
-$6.25 M(+246.2%)
-$12.05 M(+59.6%)
Jun 2013
-$7.56 M(+26.3%)
-$1.81 M(-35.7%)
-$7.55 M(+2.9%)
Mar 2013
-
-$2.81 M(+136.0%)
-$7.33 M(+12.7%)
Dec 2012
-
-$1.19 M(-32.0%)
-$6.50 M(-1.4%)
Sep 2012
-
-$1.75 M(+10.1%)
-$6.60 M(+11.2%)
Jun 2012
-$5.99 M(+0.6%)
-$1.59 M(-19.6%)
-$5.93 M(+12.3%)
Mar 2012
-
-$1.98 M(+54.2%)
-$5.28 M(-9.1%)
Dec 2011
-
-$1.28 M(+18.1%)
-$5.81 M(-2.7%)
Sep 2011
-
-$1.09 M(+15.6%)
-$5.97 M(+0.4%)
Jun 2011
-$5.95 M(+22.7%)
-$939.40 K(-62.5%)
-$5.95 M(+2.2%)
Mar 2011
-
-$2.50 M(+73.3%)
-$5.82 M(+2.0%)
Dec 2010
-
-$1.45 M(+36.3%)
-$5.70 M(+10.1%)
Sep 2010
-
-$1.06 M(+31.0%)
-$5.18 M(+6.9%)
Jun 2010
-$4.85 M(+72.7%)
-$809.20 K(-66.1%)
-$4.85 M(+4.0%)
Mar 2010
-
-$2.39 M(+159.3%)
-$4.66 M(+52.3%)
Dec 2009
-
-$921.60 K(+26.7%)
-$3.06 M(+10.1%)
Sep 2009
-
-$727.30 K(+16.9%)
-$2.78 M(-1.0%)
Jun 2009
-$2.81 M(+1.0%)
-$622.10 K(-21.1%)
-$2.81 M(-11.6%)
Mar 2009
-
-$788.60 K(+22.9%)
-$3.18 M(-0.5%)
Dec 2008
-
-$641.50 K(-15.1%)
-$3.19 M(+8.1%)
Sep 2008
-
-$755.20 K(-23.7%)
-$2.95 M(+6.3%)
Jun 2008
-$2.78 M(-8.8%)
-$990.20 K(+23.3%)
-$2.78 M(+9.6%)
Mar 2008
-
-$803.30 K(+99.0%)
-$2.54 M(-4.7%)
Dec 2007
-
-$403.70 K(-30.6%)
-$2.66 M(-10.2%)
Sep 2007
-
-$581.40 K(-22.2%)
-$2.96 M(-2.8%)
Jun 2007
-$3.05 M(+23.6%)
-$746.90 K(-19.5%)
-$3.05 M(+32.5%)
Mar 2007
-
-$927.70 K(+31.4%)
-$2.30 M(+67.6%)
Dec 2006
-
-$705.80 K(+5.9%)
-$1.37 M(+105.9%)
Sep 2006
-
-$666.20 K
-$666.20 K
Jun 2006
-$2.46 M(+3633.3%)
-
-
Jun 2005
-$66.00 K
-
-

FAQ

  • What is NanoViricides annual EBITDA?
  • What is the all time high annual EBITDA for NanoViricides?
  • What is NanoViricides annual EBITDA year-on-year change?
  • What is NanoViricides quarterly EBITDA?
  • What is the all time high quarterly EBITDA for NanoViricides?
  • What is NanoViricides quarterly EBITDA year-on-year change?
  • What is NanoViricides TTM EBITDA?
  • What is the all time high TTM EBITDA for NanoViricides?
  • What is NanoViricides TTM EBITDA year-on-year change?

What is NanoViricides annual EBITDA?

The current annual EBITDA of NNVC is -$7.49 M

What is the all time high annual EBITDA for NanoViricides?

NanoViricides all-time high annual EBITDA is $1.93 M

What is NanoViricides annual EBITDA year-on-year change?

Over the past year, NNVC annual EBITDA has changed by +$354.80 K (+4.53%)

What is NanoViricides quarterly EBITDA?

The current quarterly EBITDA of NNVC is -$1.83 M

What is the all time high quarterly EBITDA for NanoViricides?

NanoViricides all-time high quarterly EBITDA is $4.10 M

What is NanoViricides quarterly EBITDA year-on-year change?

Over the past year, NNVC quarterly EBITDA has changed by $0.00 (0.00%)

What is NanoViricides TTM EBITDA?

The current TTM EBITDA of NNVC is -$8.59 M

What is the all time high TTM EBITDA for NanoViricides?

NanoViricides all-time high TTM EBITDA is $1.68 M

What is NanoViricides TTM EBITDA year-on-year change?

Over the past year, NNVC TTM EBITDA has changed by $0.00 (0.00%)